Thursday, June 03, 2021 2:58:06 PM
Whatever AP submitted to the FDA is what will be discussed. '
I posted info that would've told you the EOP2 Meeting isn't subjected to half ass/half baked trickling out data.
Meaning, they will discuss what has been submitted within the 4 corners of the documents within the time frame allotted for the meeting.
Any after the fact stuff is just that.
After the fact.
It's pass or fail.
So we can only hope the CEO got his story straight beforehand.
There isn't any do overs dude.
The FDA will be on to the next one.
Yuh-heard!
M$
Outro
ILUS Provides an Update on the Binding Term Sheet Signed with Actelis Networks (NASDAQ: ASNS) • ILUS • May 31, 2024 12:52 PM
Element79 Gold To Provide Summary and Update on Active Exploration Program, Community Relations at RMEC on June 4 • ELEM • May 30, 2024 1:18 PM
Branded Legacy Secures Exclusive Extraction Partnership with One of the World's Largest Kava Distributors and Producers • BLEG • May 30, 2024 8:30 AM
ECGI Holdings, Inc. Announces $2 Million Debt-to-Equity Conversion • ECGI • May 30, 2024 8:30 AM
North Bay Resources Reports Assays up to >25% Mg, 0.1% Ni, 0.1% Cu, 0.01% Co, 0.3 ppm Pt at Tulameen Platinum Project, British Columbia • NBRI • May 29, 2024 9:03 AM
One World Products, Inc. Issues Shareholder Update • OWPC • May 29, 2024 8:20 AM